Stool DNA test

The Mayo Clinic Diet Book, learn more

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Results

By Mayo Clinic staff

Living With Cancer

Subscribe to our Living With Cancer e-newsletter to stay up to date on cancer topics.

Sign up now

Your doctor will review the results of your stool DNA test and then share the results with you.

  • Negative result. A test is considered negative if DNA markers common to colon cancer or precancerous polyps are not found in your stool.
  • Positive result. A test is considered positive if DNA markers common to colon cancer or precancerous polyps are found in your stool sample. Additional evaluation — usually colonoscopy — would be recommended to determine whether you have cancerous or precancerous changes in your colon or other parts of your digestive system.
  • False-negative result. A false-negative result — a negative test result when cancer is present — may occur if colon cancer or polyps do not harbor DNA markers targeted by the stool DNA test, or if markers are present in extremely low amounts. While next-generation stool DNA test methods appear to be capable of detecting most colon cancers and precancerous polyps, further study is needed to determine what the rate of false-negative results will be.
  • False-positive result. A false-positive result — a positive test for cancer when no cancer is present — may occur in about 5 to 10 percent of people screened. False-positives could be due to the presence of tumors above the colon or to a problem with the test. When the stool DNA test result is positive but a follow-up colonoscopy is normal, your doctor may recommend further observation with another stool DNA test, evaluation of your upper gastrointestinal tract, a repeat colonoscopy or a combination of these. Research is being done to clarify the best way to manage false-positive results.
References
  1. Fletcher RH. Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy. http://www.uptodate.com/home/index.html. Accessed April 12, 2011.
  2. Labianca R, et al. Screening and diagnosis for colorectal cancer: Present and future. Tumori. 2010;96:889.
  3. Levin B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA: A Cancer Journal for Clinicians. 2008;158:130.
  4. Ahlquist DA. Next generation stool DNA testing: Expanding the scope. Gastroenterology. 2009;136:2068.
  5. Ahlquist DA. Molecular detection of colorectal neoplasia. Gastroenterology. 2010;138:2127.
  6. Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology. 2010;138:2115.
  7. Lansdorp-Vogelaar I, et al. Stool DNA testing to screen for colorectal cancer in the Medicare population: A cost-effectiveness analysis. Annals of Internal Medicine. 2010;153:368.
MY00623 June 18, 2011

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger